-
Signature
-
/s/ Kathleen Lenox, attorney-in-fact
-
Issuer symbol
-
BKV
-
Transactions as of
-
01 Jul 2025
-
Net transactions value
-
-$2,370
-
Form type
-
4
-
Filing time
-
01 Jul 2025, 12:43:48 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Tameron David |
Chief Financial Officer |
1200 17TH STREET, SUITE 2100, DENVER |
/s/ Kathleen Lenox, attorney-in-fact |
01 Jul 2025 |
0001954214 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BKV |
Common Stock |
Sale |
$2,370 |
-100 |
-0.23% |
$23.70 |
43,270 |
01 Jul 2025 |
Direct |
F1 |
| holding |
BKV |
Common Stock |
|
|
|
|
|
300 |
01 Jul 2025 |
By Son |
|
| holding |
BKV |
Common Stock |
|
|
|
|
|
300 |
01 Jul 2025 |
By Son |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: